NAP1L1 and lung adenocarcinoma: NAP1L1 overexpression has been associated with a poor prognostic outcome and has previously been found to promote cellular proliferation in various neoplastic conditions including colorectal cancer, HCC, lung adenocarcinoma, and neuroendocrine cancers (Zhu et al., 2022).